Moiz Diwan is a Director within the Process Research and Development organization at AbbVie. He has led early to late-stage pharmaceutical development teams involving drug substance control strategy development, establishing global supply chain, process tech-transfer and scale-up, and authored global regulatory filings for first gen HCV Viekira and HCV next gen Mavyret drugs. Presently, Moiz leads a Center of Excellence, a cross functional team of chemists, engineers, and PAT scientists focusing on fundamentals-driven process development through application of enabling technologies, data-rich experimentation, and predictive modeling. This center has supported commercial process development and regulatory submission of five drugs in the last four years. Moiz is passionate about people, building and sustaining high performance organizations, continuous learning, and translating science and innovation into products that make a difference to human health.
Dr.Diwan has captured his scientific contributions in over 50 journal publications, patents, book chapters, and invited seminars and conference presentations. He is a Board member of AIChE’s PD2M Committee and the Purdue Chemical Engineering Industrial Advisory Committee. Moiz has received several awards for his accomplishments and has a bachelor’s degree from Indian Institute of Technology and M.S. and Ph.D. degrees from Purdue University, all in chemical engineering.